SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tenchusatsu who wrote (1341677)2/8/2022 6:26:26 PM
From: Winfastorlose2 Recommendations

Recommended By
Mick Mørmøny
tntpal

  Read Replies (1) of 1574683
 
Pfizer Quietly Adds Language Warning That 'Unfavorable Pre-Clinical, Clinical Or Safety Data' May Impact Business

TUESDAY, FEB 08, 2022 - 03:40 PM

Two weeks ago, the FDA begged a Texas judge to delay production on the first monthly batch of 55,000 pages of Covid-19 vaccine data submitted to the agency by Pfizer. Originally, the agency was set to produce just 500 pages-per-month.

[url=][/url]

Now, Pfizer - which just forecast $54 billion in Covid-related sales in 2022, appears to be anticipating some bad news, as evidenced by several redline changes in their Q4 earnings releases.

As Rubicon Capital's Kelly Brown notes on Twitter, the changes center around disclosures of unfavorable safety data.

For example, in Q4 they added: "or further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection."

[url=][/url]

More from Brown, who notes that Pfizer is now highlighting "concerns about clinical data integrity..."

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext